Trial Outcomes & Findings for A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) (NCT NCT03535194)
NCT ID: NCT03535194
Last Updated: 2021-03-30
Results Overview
The sPGA is the physician's determination of the participant's psoriasis lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participant's psoriasis was assessed as 0 (clear), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe), or 5 (very severe). An sPGA responder was defined as having a post-baseline sPGA score of "0" or "1" with at least a 2-point improvement from baseline.
Recruitment status
COMPLETED
Study phase
PHASE3
Target enrollment
1484 participants
Primary outcome timeframe
Week 16
Results posted on
2021-03-30
Participant Flow
Participant milestones
| Measure |
250mg Q4W/250mg Q8W Mirikizumab
Participants received 250 Milligrams (mg) Mirikizumab once every four weeks (Q4W) by subcutaneous injection during blinded induction period followed by 250mg Mirikizumab once every eight weeks (Q8W).
Participants received matching placebo to blind Secukinumab.
|
250mg Q4W/125mg Q8W Mirikizumab
Participants received 250mg Mirikizumab once every four weeks (Q4W) by subcutaneous injection during blinded induction period followed by 125mg Mirikizumab once every eight weeks (Q8W) in maintenance period.
Participants received matching placebo to blind Secukinumab.
|
Placebo/250mg Mirikizumab
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period followed by 250mg Mirikizumab Q4W from week 16 to 32 followed by 250mg Mirikizumab Q8W from week 32 to 48 in maintenance period. Participants received matching placebo to blind Secukinumab.
|
300mg Secukinumab
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period followed by 300mg Secukinumab Q4W from week 16 to 52 in maintenance period.
|
Japan GPP/EP
Participants received 250mg Mirikizumab Q4W in induction period followed by 250mg Q8W in maintenance period by subcutaneous injection.
|
|---|---|---|---|---|---|
|
Induction Period
STARTED
|
454
|
451
|
112
|
448
|
19
|
|
Induction Period
Received at Least One Dose of Study Drug
|
454
|
450
|
112
|
448
|
19
|
|
Induction Period
COMPLETED
|
443
|
434
|
104
|
437
|
19
|
|
Induction Period
NOT COMPLETED
|
11
|
17
|
8
|
11
|
0
|
|
Maintenance Period
STARTED
|
443
|
434
|
104
|
437
|
19
|
|
Maintenance Period
COMPLETED
|
421
|
418
|
96
|
400
|
13
|
|
Maintenance Period
NOT COMPLETED
|
22
|
16
|
8
|
37
|
6
|
|
Post-Treatment Followup Period
STARTED
|
38
|
35
|
18
|
47
|
8
|
|
Post-Treatment Followup Period
COMPLETED
|
27
|
21
|
7
|
23
|
8
|
|
Post-Treatment Followup Period
NOT COMPLETED
|
11
|
14
|
11
|
24
|
0
|
Reasons for withdrawal
| Measure |
250mg Q4W/250mg Q8W Mirikizumab
Participants received 250 Milligrams (mg) Mirikizumab once every four weeks (Q4W) by subcutaneous injection during blinded induction period followed by 250mg Mirikizumab once every eight weeks (Q8W).
Participants received matching placebo to blind Secukinumab.
|
250mg Q4W/125mg Q8W Mirikizumab
Participants received 250mg Mirikizumab once every four weeks (Q4W) by subcutaneous injection during blinded induction period followed by 125mg Mirikizumab once every eight weeks (Q8W) in maintenance period.
Participants received matching placebo to blind Secukinumab.
|
Placebo/250mg Mirikizumab
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period followed by 250mg Mirikizumab Q4W from week 16 to 32 followed by 250mg Mirikizumab Q8W from week 32 to 48 in maintenance period. Participants received matching placebo to blind Secukinumab.
|
300mg Secukinumab
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period followed by 300mg Secukinumab Q4W from week 16 to 52 in maintenance period.
|
Japan GPP/EP
Participants received 250mg Mirikizumab Q4W in induction period followed by 250mg Q8W in maintenance period by subcutaneous injection.
|
|---|---|---|---|---|---|
|
Induction Period
Adverse Event
|
2
|
2
|
1
|
3
|
0
|
|
Induction Period
Death
|
0
|
1
|
0
|
0
|
0
|
|
Induction Period
Lack of Efficacy
|
1
|
3
|
2
|
2
|
0
|
|
Induction Period
Lost to Follow-up
|
3
|
5
|
2
|
3
|
0
|
|
Induction Period
Physician Decision
|
1
|
1
|
0
|
0
|
0
|
|
Induction Period
Protocol Violation
|
1
|
0
|
0
|
1
|
0
|
|
Induction Period
Screen Failure
|
0
|
1
|
0
|
0
|
0
|
|
Induction Period
Withdrawal by Subject
|
3
|
4
|
3
|
2
|
0
|
|
Maintenance Period
Adverse Event
|
6
|
5
|
1
|
11
|
4
|
|
Maintenance Period
Lack of Efficacy
|
3
|
2
|
5
|
9
|
0
|
|
Maintenance Period
Lost to Follow-up
|
4
|
2
|
1
|
5
|
2
|
|
Maintenance Period
Other
|
1
|
2
|
0
|
0
|
0
|
|
Maintenance Period
Physician Decision
|
1
|
2
|
0
|
2
|
0
|
|
Maintenance Period
Pregnancy
|
0
|
0
|
0
|
2
|
0
|
|
Maintenance Period
Protocol Violation
|
0
|
1
|
0
|
0
|
0
|
|
Maintenance Period
Withdrawal by Subject
|
7
|
2
|
1
|
8
|
0
|
|
Post-Treatment Followup Period
Adverse Event
|
4
|
5
|
1
|
8
|
0
|
|
Post-Treatment Followup Period
Lack of Efficacy
|
3
|
4
|
5
|
4
|
0
|
|
Post-Treatment Followup Period
Lost to Follow-up
|
1
|
1
|
1
|
0
|
0
|
|
Post-Treatment Followup Period
Other
|
1
|
0
|
0
|
5
|
0
|
|
Post-Treatment Followup Period
Physician Decision
|
0
|
2
|
1
|
1
|
0
|
|
Post-Treatment Followup Period
Withdrawal by Subject
|
2
|
2
|
3
|
6
|
0
|
Baseline Characteristics
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Baseline characteristics by cohort
| Measure |
Mirikizumab 250mg Q4W/250mg Q8W
n=454 Participants
Participants received 250 Milligrams (mg) Mirikizumab once every four weeks (Q4W) by subcutaneous injection during blinded induction period followed by 250mg Mirikizumab once every eight weeks (Q8W) in maintenance period.
Participants received placebo at weeks 1, 2, 3 to match Secukinumab. Participants received matching placebo to blind Secukinumab.
|
250mg Mirikizumab /125mg Q8W
n=451 Participants
Participants received 250mg Mirikizumab once every four weeks (Q4W) by subcutaneous injection during blinded induction period followed by 125mg Mirikizumab once every eight weeks (Q8W) in maintenance period.
Participants received matching placebo to blind Secukinumab.
|
Placebo/250mg Mirikizumab
n=112 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period followed by 250mg Mirikizumab Q4W from week 16 to 32 followed by 250mg Mirikizumab Q8W from week 32 to 48 in maintenance period. Participants received matching placebo to blind Secukinumab.
|
300mg Secukinumab
n=448 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period followed by 300mg Secukinumab Q4W from week 16 to 52 in maintenance period.
|
Japan GPP/EP
n=19 Participants
Participants received 250mg Mirikizumab Q4W in induction period followed by 250mg Q8W in maintenance period by subcutaneous injection.
|
Total
n=1484 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age, Customized
<65
|
417 Participants
n=5 Participants
|
398 Participants
n=7 Participants
|
103 Participants
n=5 Participants
|
399 Participants
n=4 Participants
|
14 Participants
n=21 Participants
|
1331 Participants
n=10 Participants
|
|
Age, Customized
>=65
|
37 Participants
n=5 Participants
|
53 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
49 Participants
n=4 Participants
|
5 Participants
n=21 Participants
|
153 Participants
n=10 Participants
|
|
Sex: Female, Male
Female
|
158 Participants
n=5 Participants
|
140 Participants
n=7 Participants
|
30 Participants
n=5 Participants
|
137 Participants
n=4 Participants
|
1 Participants
n=21 Participants
|
466 Participants
n=10 Participants
|
|
Sex: Female, Male
Male
|
296 Participants
n=5 Participants
|
311 Participants
n=7 Participants
|
82 Participants
n=5 Participants
|
311 Participants
n=4 Participants
|
18 Participants
n=21 Participants
|
1018 Participants
n=10 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
9 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
10 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
38 Participants
n=10 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
79 Participants
n=5 Participants
|
71 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
72 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
234 Participants
n=10 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
366 Participants
n=5 Participants
|
365 Participants
n=7 Participants
|
96 Participants
n=5 Participants
|
366 Participants
n=4 Participants
|
19 Participants
n=21 Participants
|
1212 Participants
n=10 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
7 Participants
n=10 Participants
|
|
Race (NIH/OMB)
Asian
|
81 Participants
n=5 Participants
|
66 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
70 Participants
n=4 Participants
|
19 Participants
n=21 Participants
|
248 Participants
n=10 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
3 Participants
n=10 Participants
|
|
Race (NIH/OMB)
Black or African American
|
7 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
8 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
24 Participants
n=10 Participants
|
|
Race (NIH/OMB)
White
|
361 Participants
n=5 Participants
|
372 Participants
n=7 Participants
|
97 Participants
n=5 Participants
|
365 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
1195 Participants
n=10 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
6 Participants
n=10 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
1 Participants
n=10 Participants
|
PRIMARY outcome
Timeframe: Week 16Population: All randomized participants.
The sPGA is the physician's determination of the participant's psoriasis lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participant's psoriasis was assessed as 0 (clear), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe), or 5 (very severe). An sPGA responder was defined as having a post-baseline sPGA score of "0" or "1" with at least a 2-point improvement from baseline.
Outcome measures
| Measure |
Placebo
n=112 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=448 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=905 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Percentage of Participants With a Static Physician's Global Assessment (sPGA) of (0,1) With at Least a 2-point Improvement From Baseline
|
6.3 percentage of participants
Interval 1.8 to 10.7
|
76.3 percentage of participants
Interval 72.4 to 80.3
|
79.7 percentage of participants
Interval 77.0 to 82.3
|
PRIMARY outcome
Timeframe: Week 16Population: All randomized participants.
PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of scaling, redness, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 for no psoriasis (PsO) to 72 for the most severe disease. For each region the percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (no involvement) to 4 (severe involvement). Each area is scored separately and the scores then combined for the final PASI. Final PASI calculated as: sum of severity parameters for each region \* area score \* weighing factor \[head (0.1), upper limbs (0.2), trunk (0.3), lower limbs (0.4)\]. Overall scores range from 0 (no PsO) to 72 (the most severe disease).
Outcome measures
| Measure |
Placebo
n=112 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=448 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=905 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Percentage of Participants Achieving a ≥90% Improvement in Psoriasis Area and Severity Index (PASI 90) From Baseline
|
6.3 percentage of participants
Interval 1.8 to 10.7
|
72.8 percentage of participants
Interval 68.6 to 76.9
|
74.4 percentage of participants
Interval 71.5 to 77.2
|
SECONDARY outcome
Timeframe: Week 16Population: All randomized participants
PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of scaling, redness, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 for no psoriasis (PsO) to 72 for the most severe disease. For each region the percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (no involvement) to 4 (severe involvement). Each area is scored separately and the scores then combined for the final PASI. Final PASI calculated as: sum of severity parameters for each region \* area score \* weighing factor \[head (0.1), upper limbs (0.2), trunk (0.3), lower limbs (0.4)\]. Overall scores range from 0 (no PsO) to 72 (the most severe disease).
Outcome measures
| Measure |
Placebo
n=112 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=448 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=905 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Percentage of Participants Achieving a 75% Improvement in PASI 75
|
8.0 percentage of participants
Interval 3.0 to 13.1
|
89.5 percentage of participants
Interval 86.7 to 92.3
|
89.5 percentage of participants
Interval 87.5 to 91.5
|
SECONDARY outcome
Timeframe: Week 16Population: All randomized participants.
The BSA is the percentage involvement of psoriasis on each participant's body surface on a continuous scale from 0% (no involvement) to 100% (full involvement), in which 1% corresponds to the size of the participant's hand (including the palm, fingers, and thumb). The total BSA affected was the summation of individual regions affected. Percentage response is calculated by number of participants with a response divided by number of participants with non-missing values multiplied by 100.
Outcome measures
| Measure |
Placebo
n=112 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=448 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=905 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Percentage of Participants With ≤1% of Body Surface Area (BSA) With Psoriasis Involvement
|
1.8 percentage of participants
Interval 0.0 to 4.2
|
54.5 percentage of participants
Interval 49.9 to 59.1
|
53.1 percentage of participants
Interval 49.9 to 56.4
|
SECONDARY outcome
Timeframe: Week 16Population: All randomized participants with PSS symptom score of ≥1 at baseline.
PSS is a patient-administered assessment of 4 symptoms (itch, pain, stinging, and burning); 3 signs (redness, scaling, and cracking); and 1 item on the discomfort related to symptoms/signs. The overall severity for each individual symptom/sign from the patient's psoriasis is indicated by selecting the number from a numeric rating scale (NRS) of 0 to 10 that best describes the worst level of each symptom/sign in the past 24 hours, where 0=no symptom/sign and 10=worst imaginable symptom/sign. In addition, a symptoms score ranging from 0 (no symptoms) to 40 (worst imaginable symptoms), and a signs score of 0 (no signs) to 30 (worst imaginable signs) will be reported. Percentage response is calculated by number of participants with a response divided by number of participants with non-missing values multiplied by 100.
Outcome measures
| Measure |
Placebo
n=108 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=414 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=849 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Percentage of Participants With a Psoriasis Symptoms Scale (PSS) Symptom Score of 0 in Those With PSS Symptom Score of ≥1 at Baseline
|
1.9 percentage of participants
Interval 0.0 to 4.4
|
28.7 percentage of participants
Interval 24.4 to 33.1
|
25.0 percentage of participants
Interval 22.1 to 27.9
|
SECONDARY outcome
Timeframe: Week 16Population: All randomized participants with baseline DLQI Total Score ≥5.
The DLQI is a patient-reported, 10-question, quality-of-life questionnaire that covers 6 domains including symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include "Not at all," "A little," "A lot," and "Very much," with corresponding scores of 0, 1, 2, and 3 respectively. Questions 3-10 also have an additional response category of "Not relevant" which is scored as "0". For all questions, if unanswered the question is scored as "0". Totals range from 0 to 30 (less to more impairment). A DLQI total score of 0 to 1 is considered as having no effect on a patient's health-related quality of life (HRQoL), and a 5-point change from baseline is considered as the minimal clinically important difference (MCID) threshold. Percentage response is calculated by number of participants with a response divided by number of participants with non-missing values multiplied by 100.
Outcome measures
| Measure |
Placebo
n=101 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=396 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=821 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Percentage of Participants Achieving a Dermatology Life Quality Index (DLQI) Total Score of (0,1) With at Least a 5-Point Improvement (Reduction) From Baseline in Participants With a Baseline DLQI Total Score ≥5
|
5.9 percentage of participants
Interval 1.3 to 10.6
|
60.4 percentage of participants
Interval 55.5 to 65.2
|
59.6 percentage of participants
Interval 56.2 to 62.9
|
SECONDARY outcome
Timeframe: Baseline, Week 16Population: All randomized participants who had palmoplantar involvement at baseline.
The Palmoplantar PASI is a composite score derived from the sum scores for erythema, induration, and desquamation multiplied by a score for the extent of palm and sole area involvement, ranging from 0 (no PPASI) to 72 (most severe PPASI). The PPASI was only assessed if participants have palmoplantar psoriasis at baseline. Least Squares Mean (LS Mean) was calculated using mixed model repeated measures (MMRM) model with treatment, baseline value, visit, the interaction of the baseline value-by-visit, the interaction of treatment by-visit, and previous exposure to biologic therapy (yes/no), body weight (\<100 kg or \>=100 kg), and geographic region (North America or Other) as covariates.
Outcome measures
| Measure |
Placebo
n=18 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=84 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=191 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Change From Baseline in Palmoplantar Psoriasis Severity Index (PPASI) Total Score in Participants With Palmoplantar Involvement at Baseline
|
-1.33 Score on a scale
Standard Error 1.030
|
-5.79 Score on a scale
Standard Error 0.541
|
-6.28 Score on a scale
Standard Error 0.383
|
SECONDARY outcome
Timeframe: Baseline, Week 16Population: All randomized participants who had scalp Involvement at baseline.
The PSSI is a physician assessment of erythema, induration and desquamation and percent of scalp that is covered with a scores range from 0 (none) to 4 (very severe). The composite score is derived from the sum of scores for erythema, induration, and desquamation multiplied by the score recorded for the extent of the scalp area involved, 1 (\<10%) to 6 (90%-100%) with a total score ranging from 0 (less severity) to 72 (more severity).
Outcome measures
| Measure |
Placebo
n=90 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=387 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=789 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Change in Psoriasis Scalp Severity Index (PSSI) Total Score in Participants With Scalp Involvement at Baseline
|
-3.62 Score on a scale
Standard Error 0.676
|
-18.22 Score on a scale
Standard Error 0.365
|
-18.78 Score on a scale
Standard Error 0.286
|
SECONDARY outcome
Timeframe: Baseline, Week 16Population: All randomized participants who had Nail Psoriasis involvement at baseline.
The NAPSI scale is used to evaluate the severity of fingernail bed Ps and fingernail matrix PsO by area of involvement. The fingernail is divided into quadrants. Each fingernail is given a score for fingernail bed PsO 0 (none) to 4 (PsO in 4 quadrants of the fingernail) and fingernail matrix PsO 0 (none) to 4 (Ps in 4 quadrants of the matrix), depending on the presence (score of 1) or absence (score of 0) of any of the features of fingernail bed or matrix PsO in each quadrant. The sum of all fingernails equals the total NAPSI score range is from 0 (no effect) to 80 (more severe psoriasis).
Outcome measures
| Measure |
Placebo
n=54 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=235 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=492 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Change From Baseline in Nail Psoriasis Severity Index (NAPSI) Total Score in Participants With Fingernail Involvement at Baseline
|
0.20 Score on a scale
Standard Error 1.494
|
-11.24 Score on a scale
Standard Error 0.774
|
-9.38 Score on a scale
Standard Error 0.580
|
SECONDARY outcome
Timeframe: Baseline, Week 16Population: All randomized participants.
SF-36 consists of 36 questions measuring 8 health domains: physical functioning, bodily pain, role limitations due to physical problems, role limitations due to emotional problems, general health perceptions, mental health, social function, and vitality. The patient's responses are solicited using Likert scales that vary in length, with 3-6 response options per item. The SF-36 can be scored into the 8 health domains named above and two overall summary scores: physical component summary (PCS) and mental component summary (MCS) scores. The domain and summary scores range from 0 to 100; higher scores indicate better levels of function and/or better health.
Outcome measures
| Measure |
Placebo
n=112 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=448 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=905 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Change From Baseline on the 36-Item Short-Form Health Survey (SF-36) Physical Component Summary (PCS)
|
0.57 Score on a scale
Standard Error 0.633
|
4.38 Score on a scale
Standard Error 0.358
|
4.03 Score on a scale
Standard Error 0.291
|
SECONDARY outcome
Timeframe: Baseline, Week 16Population: All randomized participants.
SF-36 consists of 36 questions measuring 8 health domains: physical functioning, bodily pain, role limitations due to physical problems, role limitations due to emotional problems, general health perceptions, mental health, social function, and vitality. The patient's responses are solicited using Likert scales that vary in length, with 3-6 response options per item. The SF-36 can be scored into the 8 health domains named above and two overall summary scores: physical component summary (PCS) and mental component summary (MCS) scores. The domain and summary scores range from 0 to 100; higher scores indicate better levels of function and/or better health.
Outcome measures
| Measure |
Placebo
n=112 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=448 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=905 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Change From Baseline on the SF-36 Mental Component Summary (MCS)
|
0.50 Score on a scale
Standard Error 0.701
|
4.21 Score on a scale
Standard Error 0.398
|
4.45 Score on a scale
Standard Error 0.321
|
SECONDARY outcome
Timeframe: Week 16Population: All randomized participants with non missing baseline PatGA \>=2 data.
The PatGA is a single-item self-reported instrument asking the participant to rate the severity of their psoriasis "today" by circling a number on the numeric rating scale from 0 (Clear = no psoriasis) to 5 (Severe = the worst their psoriasis has ever been). Percentage response is calculated by number of participants with a response divided by number of participants with non-missing values multiplied by 100.
Outcome measures
| Measure |
Placebo
n=110 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=433 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=883 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Percentage of Participants Achieving Patient's Global Assessment (PatGA) of Disease Severity of (0,1) With at Least a 2-point Improvement From Baseline in Patients With a Baseline PatGA ≥2
|
7.3 percentage of participants
Interval 2.4 to 12.1
|
71.8 percentage of participants
Interval 67.6 to 76.1
|
72.3 percentage of participants
Interval 69.3 to 75.2
|
SECONDARY outcome
Timeframe: Baseline, Week 16Population: All randomized participants with baseline employment status of yes.
The WPAI-PSO consists of 6 questions to determine employment status, hours missed from work because of psoriasis, hours missed from work for other reasons, hours actually worked, the degree to which psoriasis affected work productivity while at work, and the degree to which psoriasis affected activities outside of work. Four scores are derived: absenteeism, presenteeism (reduced productivity while at work), an overall work impairment score that combines absenteeism and presenteeism and impairment in activities performed outside of work. Each WPAI score is expressed as impairment percentages (0-100) with higher numbers indicating greater impairment and less productivity, that is, worse outcomes.
Outcome measures
| Measure |
Placebo
n=84 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=320 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=617 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Change From Baseline for the Work Productivity and Activity Impairment Questionnaire: Psoriasis (WPAI-PSO) Scores
Absenteeism
|
-0.48 Score on a scale
Standard Error 1.753
|
-2.48 Score on a scale
Standard Error 0.995
|
-2.20 Score on a scale
Standard Error 0.844
|
|
Change From Baseline for the Work Productivity and Activity Impairment Questionnaire: Psoriasis (WPAI-PSO) Scores
Impairment in Activities Performed Outside of Work
|
-5.86 Score on a scale
Standard Error 1.847
|
-25.71 Score on a scale
Standard Error 1.061
|
-24.17 Score on a scale
Standard Error 0.885
|
|
Change From Baseline for the Work Productivity and Activity Impairment Questionnaire: Psoriasis (WPAI-PSO) Scores
Presenteeism
|
-3.36 Score on a scale
Standard Error 2.104
|
-18.95 Score on a scale
Standard Error 1.204
|
-18.95 Score on a scale
Standard Error 1.020
|
|
Change From Baseline for the Work Productivity and Activity Impairment Questionnaire: Psoriasis (WPAI-PSO) Scores
Overall work impairment
|
-2.77 Score on a scale
Standard Error 2.448
|
-18.49 Score on a scale
Standard Error 1.401
|
-19.21 Score on a scale
Standard Error 1.187
|
SECONDARY outcome
Timeframe: Baseline, Week 16Population: All participants who had a baseline QIDS-SR16 total score \>=11.
QIDS-SR16 is a participant-administered, 16-item instrument intended to assess the existence and severity of symptoms of depression. A participant is asked to consider each statement as it relates to the way they have felt for the past 7 days and rate each on a 4-point scale: 0 (best) to 3 (worst). The sum of the 16 items corresponding to 9 depression domains \[sad mood, concentration, self-criticism, suicidal ideation, interest, energy/fatigue, sleep disturbance (initial, middle and late insomnia or hypersomnia), decrease/increase in appetite/weight, and psychomotor agitation/retardation\] to give a single total scores range from 0 to 27, with higher scores indicating greater symptom severity. Whereas 0-5 indicates no symptoms.
Outcome measures
| Measure |
Placebo
n=5 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=44 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=93 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Change From Baseline in Quick Inventory of Depressive Symptomatology (QIDS-SR16) Total Score in Those With a Baseline QIDS-SR16 Total Score ≥11.
|
-4.79 score on a scale
Standard Error 2.266
|
-5.10 score on a scale
Standard Error 0.935
|
-5.28 score on a scale
Standard Error 0.733
|
SECONDARY outcome
Timeframe: Week 16Population: All randomized participants who received at least one dose of study drug and had evaluable PK samples.
Minimum observed serum Ctrough,ss of mirikizumab
Outcome measures
| Measure |
Placebo
n=809 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Pharmacokinetics: Minimum Observed Serum Concentration at Steady State (Ctrough,ss) of Mirikizumab
|
2.40 Microgram per milliliter (ug/mL)
Geometric Coefficient of Variation 112
|
—
|
—
|
SECONDARY outcome
Timeframe: Week 16Population: All randomized participants.
The sPGA is the physician's determination of the participant's psoriasis lesions overall at a given time point. Lesions were categorized by descriptions for induration, erythema, and scaling. Participant's psoriasis was assessed as 0 (clear), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe), or 5 (very severe). An sPGA responder was defined as having a post-baseline sPGA score of "0" or "1" with at least a 2-point improvement from baseline.
Outcome measures
| Measure |
Placebo
n=112 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=448 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=905 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Percentage of Participants With a Static Physician's Global Assessment (sPGA) of (0,1) With at Least a 2-point Improvement From Baseline (Non-inferiority)
|
6.3 percentage of participants
Interval 1.8 to 10.7
|
76.3 percentage of participants
Interval 72.4 to 80.3
|
79.7 percentage of participants
Interval 77.0 to 82.3
|
SECONDARY outcome
Timeframe: Week 16Population: All randomized participants.
PASI combines the extent of body surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of scaling, redness, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 for no psoriasis (PsO) to 72 for the most severe disease. For each region the percent area of skin involved was estimated from 0 (0%) to 6 (90%-100%) and severity was estimated by clinical signs of erythema, induration and scaling with a scores range from 0 (no involvement) to 4 (severe involvement). Each area is scored separately and the scores then combined for the final PASI. Final PASI calculated as: sum of severity parameters for each region \* area score \* weighing factor \[head (0.1), upper limbs (0.2), trunk (0.3), lower limbs (0.4)\]. Overall scores range from 0 (no PsO) to 72 (the most severe disease).
Outcome measures
| Measure |
Placebo
n=112 Participants
Participants received matching placebo at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during blinded induction period.
|
300mg Secukinumab
n=448 Participants
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Q4W Mirikizumab
n=905 Participants
Participants received 250 mg Mirikizumab once Q4W by subcutaneous injection during blinded induction period.
|
|---|---|---|---|
|
Percentage of Participants Achieving a ≥90% Improvement in Psoriasis Area and Severity Index (PASI 90) From Baseline (Non-inferiority)
|
6.3 percentage of participants
Interval 1.8 to 10.7
|
72.8 percentage of participants
Interval 68.6 to 76.9
|
74.4 percentage of participants
Interval 71.5 to 77.2
|
Adverse Events
Placebo / Induction Period
Serious events: 0 serious events
Other events: 68 other events
Deaths: 0 deaths
300mg Secukinumab / Induction Period
Serious events: 11 serious events
Other events: 257 other events
Deaths: 0 deaths
250mg Mirikizumab Q4W / Induction Period
Serious events: 15 serious events
Other events: 520 other events
Deaths: 1 deaths
250mg Mirikizumab Q4W - Japan GPP/EP / Induction Period
Serious events: 2 serious events
Other events: 14 other events
Deaths: 0 deaths
300mg Secukinumab/Maintenance Period
Serious events: 15 serious events
Other events: 292 other events
Deaths: 0 deaths
125mg Mirikizumab Q8W / Maintenance Period
Serious events: 13 serious events
Other events: 271 other events
Deaths: 0 deaths
250mg Mirikizumab Q8W / Maintenance Period
Serious events: 10 serious events
Other events: 282 other events
Deaths: 0 deaths
250mg Mirikizumab / Maintenance Period
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
250mg Mirikizumab Q8W - Japan GPP/EP / Maintenance Period
Serious events: 3 serious events
Other events: 14 other events
Deaths: 0 deaths
Placebo / Follow-up Period
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
300mg Secukinumab / Follow-up Period
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
250mg Mirikizumab Q4W / Follow-up Period
Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths
250mg Mirikizumab Q4W - Japan GPP/EP / Follow-up Period
Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths
250mg Mirikizumab Q4W/125mg Mirikizumab Q8W / Follow-up Period
Serious events: 3 serious events
Other events: 3 other events
Deaths: 0 deaths
250mg Mirikizumab Q4W/250mg Mirikizumab Q8W / Follow-up Period
Serious events: 0 serious events
Other events: 6 other events
Deaths: 0 deaths
Placebo/250mg Mirikizumab / Follow-up Period
Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths
250mg Mirikizumab Q4W/250mg Mirikizumab Q8W - Japan GPP/EP / Follow-up Period
Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths
300mg Secukinumab /300mg Secukinumab / Follow-up Period
Serious events: 0 serious events
Other events: 7 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
Placebo / Induction Period
n=112 participants at risk
Participants received matching placebo by subcutaneous injection in induction period.
|
300mg Secukinumab / Induction Period
n=448 participants at risk
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Mirikizumab Q4W / Induction Period
n=904 participants at risk
Participants received 250 Mirikizumab once every four weeks (Q4W) by subcutaneous injection during blinded induction period.
|
250mg Mirikizumab Q4W - Japan GPP/EP / Induction Period
n=19 participants at risk
Participants received 250mg Mirikizumab Q4Wby subcutaneous injection in induction period.
|
300mg Secukinumab/Maintenance Period
n=437 participants at risk
Participants received 300mg Secukinumab Q4W by subcutaneous injection from week 16 to 52 in maintenance period.
|
125mg Mirikizumab Q8W / Maintenance Period
n=434 participants at risk
Participants received 125mg Mirikizumab once every eight weeks (Q8W) by subcutaneous injection in maintenance period.
|
250mg Mirikizumab Q8W / Maintenance Period
n=443 participants at risk
Participants received 250mg Mirikizumab once every eight weeks (Q8W) by subcutaneous injection in maintenance period.
|
250mg Mirikizumab / Maintenance Period
n=104 participants at risk
Participants received 250mg Mirikizumab Q4W from week 16 to 32 followed by 250mg Mirikizumab Q8W from week 32 to 48 by subcutaneous injection in maintenance period.
|
250mg Mirikizumab Q8W - Japan GPP/EP / Maintenance Period
n=18 participants at risk
Participants received 250mg Q8W by subcutaneous injection in maintenance period
|
Placebo / Follow-up Period
n=4 participants at risk
Participants did not receive any intervention in post- treatment follow-up period.
|
300mg Secukinumab / Follow-up Period
n=4 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
250mg Mirikizumab Q4W / Follow-up Period
n=9 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
250mg Mirikizumab Q4W - Japan GPP/EP / Follow-up Period
n=1 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
250mg Mirikizumab Q4W/125mg Mirikizumab Q8W / Follow-up Period
n=29 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
250mg Mirikizumab Q4W/250mg Mirikizumab Q8W / Follow-up Period
n=35 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
Placebo/250mg Mirikizumab / Follow-up Period
n=14 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
250mg Mirikizumab Q4W/250mg Mirikizumab Q8W - Japan GPP/EP / Follow-up Period
n=6 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
300mg Secukinumab /300mg Secukinumab / Follow-up Period
n=43 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Skin and subcutaneous tissue disorders
Psoriasis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Pustular psoriasis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Gender reassignment therapy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Hernia repair
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Mammoplasty
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Tenotomy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Hypertension
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Acute myocardial infarction
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Angina pectoris
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Atrial fibrillation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Atrial flutter
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Congestive cardiomyopathy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Coronary artery disease
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Myocardial infarction
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Ear and labyrinth disorders
Hypoacusis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Cataract
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Crohn's disease
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Diarrhoea
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Enlarged uvula
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Incarcerated inguinal hernia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Inguinal hernia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Irritable bowel syndrome
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
5.3%
1/19 • Number of events 2 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Pancreatitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Pancreatitis acute
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Umbilical hernia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Chest pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Hepatobiliary disorders
Cholecystitis acute
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Immune system disorders
Anaphylactic shock
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Anal abscess
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Appendicitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Cellulitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Diverticulitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Erysipelas
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Meningitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
3.4%
1/29 • Number of events 1 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Pneumonia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Pyelonephritis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Sinusitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Wound infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Concussion
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Fibula fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Incisional hernia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Meniscus injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Pulmonary contusion
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Radius fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Road traffic accident
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Skin laceration
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Spinal compression fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Tibia fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Liver function test abnormal
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Enthesopathy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Intervertebral disc protrusion
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Osteoarthritis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Symphysiolysis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Breast cancer
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Gallbladder cancer
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Haemangioma of skin
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lung adenocarcinoma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lung adenocarcinoma stage i
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
3.4%
1/29 • Number of events 1 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Malignant melanoma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
3.4%
1/29 • Number of events 1 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Non-small cell lung cancer stage iv
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Prostate cancer
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Cerebral infarction
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Ischaemic stroke
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Monoplegia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Nerve compression
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Sacral radiculopathy
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Bipolar disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Depression
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Renal and urinary disorders
Nephrolithiasis
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Chronic obstructive pulmonary disease
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
Other adverse events
| Measure |
Placebo / Induction Period
n=112 participants at risk
Participants received matching placebo by subcutaneous injection in induction period.
|
300mg Secukinumab / Induction Period
n=448 participants at risk
Participants received 300mg Secukinumab at weeks 0, 1, 2, 3, 4, 8, and 12 by subcutaneous injection during induction period.
|
250mg Mirikizumab Q4W / Induction Period
n=904 participants at risk
Participants received 250 Mirikizumab once every four weeks (Q4W) by subcutaneous injection during blinded induction period.
|
250mg Mirikizumab Q4W - Japan GPP/EP / Induction Period
n=19 participants at risk
Participants received 250mg Mirikizumab Q4Wby subcutaneous injection in induction period.
|
300mg Secukinumab/Maintenance Period
n=437 participants at risk
Participants received 300mg Secukinumab Q4W by subcutaneous injection from week 16 to 52 in maintenance period.
|
125mg Mirikizumab Q8W / Maintenance Period
n=434 participants at risk
Participants received 125mg Mirikizumab once every eight weeks (Q8W) by subcutaneous injection in maintenance period.
|
250mg Mirikizumab Q8W / Maintenance Period
n=443 participants at risk
Participants received 250mg Mirikizumab once every eight weeks (Q8W) by subcutaneous injection in maintenance period.
|
250mg Mirikizumab / Maintenance Period
n=104 participants at risk
Participants received 250mg Mirikizumab Q4W from week 16 to 32 followed by 250mg Mirikizumab Q8W from week 32 to 48 by subcutaneous injection in maintenance period.
|
250mg Mirikizumab Q8W - Japan GPP/EP / Maintenance Period
n=18 participants at risk
Participants received 250mg Q8W by subcutaneous injection in maintenance period
|
Placebo / Follow-up Period
n=4 participants at risk
Participants did not receive any intervention in post- treatment follow-up period.
|
300mg Secukinumab / Follow-up Period
n=4 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
250mg Mirikizumab Q4W / Follow-up Period
n=9 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
250mg Mirikizumab Q4W - Japan GPP/EP / Follow-up Period
n=1 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
250mg Mirikizumab Q4W/125mg Mirikizumab Q8W / Follow-up Period
n=29 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
250mg Mirikizumab Q4W/250mg Mirikizumab Q8W / Follow-up Period
n=35 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
Placebo/250mg Mirikizumab / Follow-up Period
n=14 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
250mg Mirikizumab Q4W/250mg Mirikizumab Q8W - Japan GPP/EP / Follow-up Period
n=6 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
300mg Secukinumab /300mg Secukinumab / Follow-up Period
n=43 participants at risk
Participants did not receive any intervention in post- treatment follow-up period
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
General disorders
Dehiscence
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Hypokalaemia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Tinea pedis
|
0.00%
0/112 • Up to 64 weeks
|
1.1%
5/448 • Number of events 5 • Up to 64 weeks
|
0.77%
7/904 • Number of events 7 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.46%
2/434 • Number of events 4 • Up to 64 weeks
|
1.1%
5/443 • Number of events 5 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Tinea versicolour
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.69%
3/434 • Number of events 3 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Tonsillitis
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
1.3%
6/448 • Number of events 6 • Up to 64 weeks
|
0.66%
6/904 • Number of events 8 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.8%
8/437 • Number of events 8 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.68%
3/443 • Number of events 4 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Discomfort
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Fatigue
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
1.3%
6/448 • Number of events 6 • Up to 64 weeks
|
1.7%
15/904 • Number of events 16 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.92%
4/437 • Number of events 5 • Up to 64 weeks
|
1.4%
6/434 • Number of events 6 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
General physical health deterioration
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Increased appetite
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Blood and lymphatic system disorders
Anaemia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Blood and lymphatic system disorders
Eosinophilia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Blood and lymphatic system disorders
Iron deficiency anaemia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Blood and lymphatic system disorders
Leukocytosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Blood and lymphatic system disorders
Leukopenia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Blood and lymphatic system disorders
Lymphadenitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Blood and lymphatic system disorders
Lymphadenopathy
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Blood and lymphatic system disorders
Lymphopenia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Blood and lymphatic system disorders
Neutropenia
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Blood and lymphatic system disorders
Neutrophilia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Blood and lymphatic system disorders
Thrombocytopenia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
3.4%
1/29 • Number of events 1 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Angina pectoris
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Atrial fibrillation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Coronary artery disease
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Palpitations
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Sinus tachycardia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Tachycardia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Cardiac disorders
Ventricular extrasystoles
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Congenital, familial and genetic disorders
Distichiasis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Ear and labyrinth disorders
Auditory disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Ear and labyrinth disorders
Cerumen impaction
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Ear and labyrinth disorders
Ear discomfort
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Ear and labyrinth disorders
Ear disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Ear and labyrinth disorders
Ear pain
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Ear and labyrinth disorders
Ear swelling
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Ear and labyrinth disorders
Hypoacusis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 3 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Ear and labyrinth disorders
Tinnitus
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Ear and labyrinth disorders
Vertigo
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 4 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Ear and labyrinth disorders
Vertigo positional
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Endocrine disorders
Adrenal insufficiency
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Endocrine disorders
Goitre
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Endocrine disorders
Hypothyroidism
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Blepharitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Cataract
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Chalazion
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Conjunctival haemorrhage
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Conjunctivitis allergic
|
0.00%
0/112 • Up to 64 weeks
|
0.67%
3/448 • Number of events 3 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Corneal disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Dry eye
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Erythema of eyelid
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Eye haemorrhage
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Eye irritation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Eye pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Eye pruritus
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Eyelid oedema
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Hypermetropia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Meibomianitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Posterior capsule opacification
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Eye disorders
Vision blurred
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Abdominal discomfort
|
0.00%
0/112 • Up to 64 weeks
|
0.67%
3/448 • Number of events 3 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.90%
4/443 • Number of events 5 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Abdominal distension
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Abdominal pain
|
1.8%
2/112 • Number of events 2 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.55%
5/904 • Number of events 5 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 9 • Up to 64 weeks
|
0.92%
4/434 • Number of events 4 • Up to 64 weeks
|
1.1%
5/443 • Number of events 6 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Abdominal pain lower
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Abdominal pain upper
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
2.3%
1/43 • Number of events 1 • Up to 64 weeks
|
|
Gastrointestinal disorders
Abdominal tenderness
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Acquired oesophageal web
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Anal fissure
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Aphthous ulcer
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Chilaiditi's syndrome
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Chronic gastritis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Constipation
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.44%
4/904 • Number of events 4 • Up to 64 weeks
|
10.5%
2/19 • Number of events 2 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
2.3%
1/43 • Number of events 1 • Up to 64 weeks
|
|
Gastrointestinal disorders
Crohn's disease
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Dental caries
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Diarrhoea
|
1.8%
2/112 • Number of events 2 • Up to 64 weeks
|
3.8%
17/448 • Number of events 37 • Up to 64 weeks
|
1.9%
17/904 • Number of events 19 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
1.1%
5/437 • Number of events 27 • Up to 64 weeks
|
1.4%
6/434 • Number of events 6 • Up to 64 weeks
|
2.0%
9/443 • Number of events 10 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
3.4%
1/29 • Number of events 1 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
2.3%
1/43 • Number of events 1 • Up to 64 weeks
|
|
Gastrointestinal disorders
Diverticulum intestinal
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
16.7%
1/6 • Number of events 1 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Dry mouth
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Duodenitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Dyspepsia
|
0.00%
0/112 • Up to 64 weeks
|
0.67%
3/448 • Number of events 4 • Up to 64 weeks
|
0.66%
6/904 • Number of events 8 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.92%
4/434 • Number of events 4 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Dysphagia
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Enlarged uvula
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Enteritis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Faeces soft
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Flatulence
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Food poisoning
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Frequent bowel movements
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Gastric disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Gastric polyps
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Gastritis
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.45%
2/448 • Number of events 7 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 10 • Up to 64 weeks
|
0.69%
3/434 • Number of events 3 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Gastrolithiasis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Gastrooesophageal reflux disease
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Gastrooesophageal sphincter insufficiency
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Gingival bleeding
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Gingival pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Glossitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Haematochezia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Haemorrhoidal haemorrhage
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Haemorrhoids
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Hiatus hernia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Inflammatory bowel disease
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Inguinal hernia
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Intestinal polyp
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Irritable bowel syndrome
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
5.3%
1/19 • Number of events 2 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
100.0%
1/1 • Number of events 1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Large intestine polyp
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Loose tooth
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Lumbar hernia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Nausea
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
1.1%
10/904 • Number of events 10 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
3.4%
1/29 • Number of events 1 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Odynophagia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Oral pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Paraesthesia oral
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Peptic ulcer
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Saliva altered
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Stomatitis
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Tongue discolouration
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Toothache
|
0.89%
1/112 • Number of events 4 • Up to 64 weeks
|
0.89%
4/448 • Number of events 4 • Up to 64 weeks
|
0.88%
8/904 • Number of events 10 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.1%
5/437 • Number of events 6 • Up to 64 weeks
|
0.46%
2/434 • Number of events 4 • Up to 64 weeks
|
1.6%
7/443 • Number of events 8 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Traumatic occlusion
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Umbilical hernia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Gastrointestinal disorders
Vomiting
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.67%
3/448 • Number of events 3 • Up to 64 weeks
|
0.44%
4/904 • Number of events 4 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Asthenia
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.92%
4/434 • Number of events 4 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Chest discomfort
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Chest pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Cyst
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Granuloma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Inflammation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Influenza like illness
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.55%
5/904 • Number of events 5 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.92%
4/437 • Number of events 5 • Up to 64 weeks
|
1.2%
5/434 • Number of events 6 • Up to 64 weeks
|
1.4%
6/443 • Number of events 6 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site bruising
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site discomfort
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site erythema
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 4 • Up to 64 weeks
|
1.4%
13/904 • Number of events 27 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.92%
4/434 • Number of events 6 • Up to 64 weeks
|
0.68%
3/443 • Number of events 7 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site haematoma
|
1.8%
2/112 • Number of events 2 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site haemorrhage
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site hypersensitivity
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site induration
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site inflammation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site oedema
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.69%
3/434 • Number of events 4 • Up to 64 weeks
|
0.23%
1/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site pain
|
3.6%
4/112 • Number of events 28 • Up to 64 weeks
|
0.22%
1/448 • Number of events 6 • Up to 64 weeks
|
2.3%
21/904 • Number of events 109 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 11 • Up to 64 weeks
|
1.8%
8/434 • Number of events 38 • Up to 64 weeks
|
0.90%
4/443 • Number of events 28 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site papule
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site paraesthesia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site pruritus
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.55%
5/904 • Number of events 8 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.92%
4/434 • Number of events 8 • Up to 64 weeks
|
0.68%
3/443 • Number of events 6 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site reaction
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.89%
4/448 • Number of events 7 • Up to 64 weeks
|
2.9%
26/904 • Number of events 64 • Up to 64 weeks
|
5.3%
1/19 • Number of events 2 • Up to 64 weeks
|
0.69%
3/437 • Number of events 4 • Up to 64 weeks
|
3.2%
14/434 • Number of events 24 • Up to 64 weeks
|
3.2%
14/443 • Number of events 35 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
11.1%
2/18 • Number of events 5 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Injection site swelling
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Malaise
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Non-cardiac chest pain
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Oedema
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Oedema peripheral
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.90%
4/443 • Number of events 4 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Peripheral swelling
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Pyrexia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.66%
6/904 • Number of events 6 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 4 • Up to 64 weeks
|
0.92%
4/434 • Number of events 4 • Up to 64 weeks
|
0.68%
3/443 • Number of events 4 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
2.9%
1/35 • Number of events 1 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Swelling face
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Tenderness
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
General disorders
Xerosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Hepatobiliary disorders
Biliary dilatation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Hepatobiliary disorders
Cholelithiasis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Hepatobiliary disorders
Drug-induced liver injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Hepatobiliary disorders
Hepatic fibrosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Hepatobiliary disorders
Hepatic function abnormal
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Hepatobiliary disorders
Hepatic pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Hepatobiliary disorders
Hepatic steatosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Hepatobiliary disorders
Pneumobilia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Immune system disorders
Allergy to arthropod bite
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Immune system disorders
Food allergy
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Immune system disorders
Hypersensitivity
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Immune system disorders
Multiple allergies
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Immune system disorders
Rubber sensitivity
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Immune system disorders
Seasonal allergy
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 4 • Up to 64 weeks
|
0.69%
3/434 • Number of events 3 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Immune system disorders
Selective igg subclass deficiency
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Abdominal hernia infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Abscess
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Abscess jaw
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Abscess limb
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Acarodermatitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Anal abscess
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Asymptomatic bacteriuria
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Bacterial vaginosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Body tinea
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Bronchitis
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.89%
4/448 • Number of events 4 • Up to 64 weeks
|
1.5%
14/904 • Number of events 14 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.8%
8/437 • Number of events 8 • Up to 64 weeks
|
2.1%
9/434 • Number of events 10 • Up to 64 weeks
|
2.0%
9/443 • Number of events 9 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
2.9%
1/35 • Number of events 1 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Bronchitis viral
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Candida infection
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Cellulitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.55%
5/904 • Number of events 5 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Chronic sinusitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Conjunctivitis
|
0.00%
0/112 • Up to 64 weeks
|
0.67%
3/448 • Number of events 3 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.8%
8/437 • Number of events 9 • Up to 64 weeks
|
0.92%
4/434 • Number of events 4 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Cystitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.44%
4/904 • Number of events 4 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.69%
3/434 • Number of events 3 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Demodicidosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Dermatophytosis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Diverticulitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Ear infection
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.92%
4/437 • Number of events 4 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Ear infection bacterial
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Empyema
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Enteritis infectious
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Epididymitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Erysipelas
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Erythema infectiosum
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Erythrasma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Eye infection
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Folliculitis
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.45%
2/448 • Number of events 3 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.4%
6/437 • Number of events 6 • Up to 64 weeks
|
0.92%
4/434 • Number of events 4 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Fungal infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Fungal skin infection
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Furuncle
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.1%
5/437 • Number of events 6 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Gastroenteritis
|
1.8%
2/112 • Number of events 2 • Up to 64 weeks
|
0.67%
3/448 • Number of events 3 • Up to 64 weeks
|
1.2%
11/904 • Number of events 11 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
2.3%
10/437 • Number of events 10 • Up to 64 weeks
|
2.1%
9/434 • Number of events 9 • Up to 64 weeks
|
1.6%
7/443 • Number of events 7 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Gastroenteritis viral
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.55%
5/904 • Number of events 5 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.92%
4/434 • Number of events 4 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Gastrointestinal infection
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
2.3%
1/43 • Number of events 1 • Up to 64 weeks
|
|
Infections and infestations
Genital candidiasis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Genital herpes simplex
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Genital infection female
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Gingivitis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Groin infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Helicobacter gastritis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.69%
3/434 • Number of events 3 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Helicobacter infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Herpes simplex
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Herpes zoster
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
3.4%
1/29 • Number of events 1 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Hordeolum
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Impetigo
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.1%
5/437 • Number of events 5 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Infected dermal cyst
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Influenza
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
1.6%
7/448 • Number of events 7 • Up to 64 weeks
|
1.1%
10/904 • Number of events 10 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 3 • Up to 64 weeks
|
1.2%
5/434 • Number of events 5 • Up to 64 weeks
|
1.1%
5/443 • Number of events 5 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Kidney infection
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Labyrinthitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Laryngitis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Localised infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Lyme disease
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Mastitis
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Mastoiditis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Molluscum contagiosum
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
7.1%
1/14 • Number of events 1 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Mycoplasma infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Myringitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Nasopharyngitis
|
16.1%
18/112 • Number of events 22 • Up to 64 weeks
|
12.3%
55/448 • Number of events 71 • Up to 64 weeks
|
15.9%
144/904 • Number of events 168 • Up to 64 weeks
|
21.1%
4/19 • Number of events 5 • Up to 64 weeks
|
14.0%
61/437 • Number of events 81 • Up to 64 weeks
|
13.8%
60/434 • Number of events 73 • Up to 64 weeks
|
15.1%
67/443 • Number of events 82 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
22.2%
4/18 • Number of events 4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
11.1%
1/9 • Number of events 1 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
33.3%
2/6 • Number of events 2 • Up to 64 weeks
|
4.7%
2/43 • Number of events 2 • Up to 64 weeks
|
|
Infections and infestations
Onychomycosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Oral candidiasis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Oral fungal infection
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Oral herpes
|
0.00%
0/112 • Up to 64 weeks
|
1.3%
6/448 • Number of events 6 • Up to 64 weeks
|
0.55%
5/904 • Number of events 5 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.92%
4/437 • Number of events 4 • Up to 64 weeks
|
0.69%
3/434 • Number of events 5 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
2.9%
1/35 • Number of events 1 • Up to 64 weeks
|
7.1%
1/14 • Number of events 1 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Otitis externa
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.6%
7/437 • Number of events 8 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
7.1%
1/14 • Number of events 1 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Otitis media
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.46%
2/437 • Number of events 3 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
16.7%
1/6 • Number of events 1 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Otitis media acute
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Parasitic gastroenteritis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Paronychia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Periodontitis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Pharyngitis
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
2.0%
9/448 • Number of events 9 • Up to 64 weeks
|
0.77%
7/904 • Number of events 7 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
3.0%
13/437 • Number of events 16 • Up to 64 weeks
|
1.4%
6/434 • Number of events 7 • Up to 64 weeks
|
0.90%
4/443 • Number of events 6 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Pharyngitis bacterial
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Pharyngitis streptococcal
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Pharyngotonsillitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Pneumonia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
2.9%
1/35 • Number of events 1 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Postoperative wound infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Pulpitis dental
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.92%
4/437 • Number of events 4 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Pyoderma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Respiratory tract infection
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Rhinitis
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
1.3%
6/448 • Number of events 6 • Up to 64 weeks
|
1.8%
16/904 • Number of events 16 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
1.2%
5/434 • Number of events 6 • Up to 64 weeks
|
1.1%
5/443 • Number of events 5 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Sinusitis
|
0.00%
0/112 • Up to 64 weeks
|
0.89%
4/448 • Number of events 5 • Up to 64 weeks
|
1.2%
11/904 • Number of events 11 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.4%
6/437 • Number of events 6 • Up to 64 weeks
|
1.6%
7/434 • Number of events 7 • Up to 64 weeks
|
1.6%
7/443 • Number of events 7 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Sinusitis bacterial
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Skin bacterial infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Skin candida
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Skin infection
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Staphylococcal abscess
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Staphylococcal infection
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Staphylococcal skin infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Subcutaneous abscess
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Syphilis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Tinea cruris
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Tinea infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Tonsillitis bacterial
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Tooth abscess
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Tooth infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Upper respiratory tract infection
|
3.6%
4/112 • Number of events 5 • Up to 64 weeks
|
8.7%
39/448 • Number of events 46 • Up to 64 weeks
|
5.9%
53/904 • Number of events 64 • Up to 64 weeks
|
5.3%
1/19 • Number of events 2 • Up to 64 weeks
|
8.0%
35/437 • Number of events 46 • Up to 64 weeks
|
6.9%
30/434 • Number of events 40 • Up to 64 weeks
|
6.5%
29/443 • Number of events 36 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
2.9%
1/35 • Number of events 1 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Upper respiratory tract infection bacterial
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Urinary tract infection
|
0.00%
0/112 • Up to 64 weeks
|
1.3%
6/448 • Number of events 6 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.1%
5/437 • Number of events 5 • Up to 64 weeks
|
0.69%
3/434 • Number of events 3 • Up to 64 weeks
|
1.1%
5/443 • Number of events 6 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Vaginal infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Viral infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 3 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Viral pharyngitis
|
0.00%
0/112 • Up to 64 weeks
|
0.67%
3/448 • Number of events 3 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Viral sinusitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Viral upper respiratory tract infection
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
1.00%
9/904 • Number of events 9 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.69%
3/434 • Number of events 3 • Up to 64 weeks
|
1.1%
5/443 • Number of events 5 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Vulvovaginal candidiasis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 3 • Up to 64 weeks
|
0.44%
4/904 • Number of events 4 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Vulvovaginal mycotic infection
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 2 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Infections and infestations
Wound infection
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Arthropod bite
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Arthropod sting
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Chemical burn
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Concussion
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Contusion
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.1%
5/437 • Number of events 5 • Up to 64 weeks
|
0.92%
4/434 • Number of events 4 • Up to 64 weeks
|
0.45%
2/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
2.9%
1/35 • Number of events 1 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Craniocerebral injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Epicondylitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
7.1%
1/14 • Number of events 1 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Eye contusion
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Eye injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Face injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Fall
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.66%
6/904 • Number of events 6 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Foot fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
2.3%
1/43 • Number of events 1 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Hand fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
2.3%
1/43 • Number of events 1 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Head injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Heat stroke
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Humerus fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Injury corneal
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Joint dislocation
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Joint injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Ligament injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Ligament sprain
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.66%
6/904 • Number of events 6 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
1.2%
5/434 • Number of events 7 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Limb crushing injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Limb fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Limb injury
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 2 • Up to 64 weeks
|
0.44%
4/904 • Number of events 4 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Lower limb fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Mallet finger
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Meniscus injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Multiple injuries
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Muscle injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Muscle rupture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Muscle strain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.77%
7/904 • Number of events 8 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.92%
4/434 • Number of events 4 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Patella fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Post-traumatic neck syndrome
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Post-traumatic pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Procedural pain
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Radius fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Rib fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Road traffic accident
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Scratch
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Skin abrasion
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Skin injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Skin laceration
|
1.8%
2/112 • Number of events 2 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.22%
2/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Skin wound
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Sternal injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Tendon rupture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Thermal burn
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Tooth fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Traumatic haematoma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Traumatic ulcer
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Upper limb fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Wound
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 3 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Injury, poisoning and procedural complications
Wrist fracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Alanine aminotransferase increased
|
0.00%
0/112 • Up to 64 weeks
|
0.67%
3/448 • Number of events 4 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 4 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.90%
4/443 • Number of events 4 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
2.9%
1/35 • Number of events 1 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Anti-actin antibody positive
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Aspartate aminotransferase increased
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 3 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
1.1%
5/443 • Number of events 5 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
2.9%
1/35 • Number of events 1 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Aspiration joint
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Biopsy skin
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
16.7%
1/6 • Number of events 1 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood bilirubin increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood cholesterol increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood creatine increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood creatine phosphokinase abnormal
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood creatine phosphokinase increased
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
1.3%
12/904 • Number of events 12 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
1.6%
7/434 • Number of events 8 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood creatinine increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood glucose increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood iron decreased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood potassium increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood pressure increased
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood thyroid stimulating hormone decreased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood triglycerides increased
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.92%
4/437 • Number of events 4 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Blood uric acid increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Body temperature increased
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Female sex hormone level abnormal
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Fibrin d dimer increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Gamma-glutamyltransferase abnormal
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Gamma-glutamyltransferase increased
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 3 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Haemoglobin increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Hepatic enzyme increased
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Hepatitis e virus test positive
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Liver function test abnormal
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Liver function test increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Lymph node palpable
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Lymphocyte count decreased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Lymphocyte morphology abnormal
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Mammogram
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Neutrophil count decreased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Neutrophil count increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Occult blood
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Panendoscopy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Platelet count decreased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Platelet count increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Prostatic specific antigen increased
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Protein urine present
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Red blood cell count decreased
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Transaminases increased
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Very low density lipoprotein increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Vitamin d decreased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Weight decreased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.69%
3/434 • Number of events 3 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
16.7%
1/6 • Number of events 1 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
Weight increased
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.22%
2/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.92%
4/434 • Number of events 4 • Up to 64 weeks
|
0.90%
4/443 • Number of events 4 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
White blood cell count decreased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Investigations
White blood cell count increased
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Cachexia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Decreased appetite
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Diabetes mellitus
|
0.00%
0/112 • Up to 64 weeks
|
0.67%
3/448 • Number of events 3 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Dyslipidaemia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Food craving
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Gout
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Hypercholesterolaemia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Hyperglycaemia
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.67%
3/448 • Number of events 3 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Hyperlipidaemia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Hypertriglyceridaemia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.44%
4/904 • Number of events 5 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Hyperuricaemia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Hypocholesterolaemia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Iron deficiency
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Metabolic syndrome
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Obesity
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Polydipsia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Type 2 diabetes mellitus
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Metabolism and nutrition disorders
Vitamin d deficiency
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Arthralgia
|
2.7%
3/112 • Number of events 5 • Up to 64 weeks
|
1.1%
5/448 • Number of events 5 • Up to 64 weeks
|
2.2%
20/904 • Number of events 25 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.8%
8/437 • Number of events 9 • Up to 64 weeks
|
4.1%
18/434 • Number of events 19 • Up to 64 weeks
|
2.9%
13/443 • Number of events 17 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
2.3%
1/43 • Number of events 1 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Arthritis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Back pain
|
4.5%
5/112 • Number of events 5 • Up to 64 weeks
|
0.67%
3/448 • Number of events 4 • Up to 64 weeks
|
2.4%
22/904 • Number of events 22 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
3.0%
13/437 • Number of events 14 • Up to 64 weeks
|
4.4%
19/434 • Number of events 19 • Up to 64 weeks
|
4.3%
19/443 • Number of events 22 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
2.9%
1/35 • Number of events 1 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Bone pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Bursitis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Chondrocalcinosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Connective tissue disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Enthesopathy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Exostosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Facet joint syndrome
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Flank pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Foot deformity
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Inclusion body myositis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Intervertebral disc degeneration
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Intervertebral disc protrusion
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Joint swelling
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Muscle contracture
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Muscle spasms
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 4 • Up to 64 weeks
|
0.69%
3/434 • Number of events 3 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Muscle tightness
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Muscular weakness
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Musculoskeletal chest pain
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.69%
3/434 • Number of events 4 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Musculoskeletal discomfort
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Musculoskeletal pain
|
0.00%
0/112 • Up to 64 weeks
|
0.67%
3/448 • Number of events 4 • Up to 64 weeks
|
0.88%
8/904 • Number of events 8 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
1.6%
7/443 • Number of events 7 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Musculoskeletal stiffness
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Myalgia
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 3 • Up to 64 weeks
|
1.1%
10/904 • Number of events 10 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Myositis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Neck pain
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.55%
5/904 • Number of events 5 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Osteitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Osteoarthritis
|
1.8%
2/112 • Number of events 2 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 3 • Up to 64 weeks
|
1.2%
5/434 • Number of events 5 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Pain in extremity
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.66%
6/904 • Number of events 6 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
1.2%
5/434 • Number of events 5 • Up to 64 weeks
|
1.8%
8/443 • Number of events 8 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Periarthritis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Polyarthritis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Psoriatic arthropathy
|
1.8%
2/112 • Number of events 2 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Rotator cuff syndrome
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Spinal osteoarthritis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Spinal pain
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 3 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Synovial cyst
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Synovitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Tendonitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.90%
4/443 • Number of events 4 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Tenosynovitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.92%
4/437 • Number of events 4 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Tenosynovitis stenosans
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Musculoskeletal and connective tissue disorders
Trigger finger
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Anogenital warts
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
B-cell lymphoma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Basal cell carcinoma
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.33%
3/904 • Number of events 4 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Dysplastic naevus
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lentigo maligna
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lip neoplasm malignant stage unspecified
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lipoma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lung adenocarcinoma stage i
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lymphoma
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Melanocytic naevus
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Neoplasm
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Neoplasm skin
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Oral fibroma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Prostate cancer
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Seborrhoeic keratosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Skin papilloma
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Squamous cell carcinoma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Uterine leiomyoma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Burning sensation
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Carpal tunnel syndrome
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Cervicobrachial syndrome
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
2.9%
1/35 • Number of events 1 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Disturbance in attention
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Dizziness
|
1.8%
2/112 • Number of events 2 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
1.00%
9/904 • Number of events 10 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Dysaesthesia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Dysgeusia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Facial paralysis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Headache
|
3.6%
4/112 • Number of events 4 • Up to 64 weeks
|
5.4%
24/448 • Number of events 27 • Up to 64 weeks
|
4.9%
44/904 • Number of events 63 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
2.1%
9/437 • Number of events 14 • Up to 64 weeks
|
3.7%
16/434 • Number of events 20 • Up to 64 weeks
|
4.3%
19/443 • Number of events 38 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
3.4%
1/29 • Number of events 1 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Hypertonia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Hypoaesthesia
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Loss of consciousness
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Migraine
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 5 • Up to 64 weeks
|
0.22%
2/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 4 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.90%
4/443 • Number of events 4 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Nerve compression
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Neuralgia
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Notalgia paraesthetica
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Paraesthesia
|
0.89%
1/112 • Number of events 2 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Presyncope
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Sciatica
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Senile dementia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Sinus headache
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Somnolence
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Syncope
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Taste disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Tension headache
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Nervous system disorders
Trigeminal neuralgia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Product Issues
Device breakage
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Product Issues
Device physical property issue
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Abnormal dreams
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Acute stress disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Adjustment disorder with depressed mood
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Alcoholic psychosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Anxiety
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.33%
3/904 • Number of events 4 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Anxiety disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Attention deficit hyperactivity disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Burnout syndrome
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Depressed mood
|
1.8%
2/112 • Number of events 2 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Depression
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Insomnia
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 9 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Irritability
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Libido decreased
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Loss of libido
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Mood altered
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Panic attack
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Sleep disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.44%
4/904 • Number of events 6 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Social anxiety disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Psychiatric disorders
Stress
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Renal and urinary disorders
Acute kidney injury
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Renal and urinary disorders
Calculus urinary
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Renal and urinary disorders
Dysuria
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Renal and urinary disorders
Haematuria
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Renal and urinary disorders
Micturition urgency
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Renal and urinary disorders
Nephrolithiasis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
2.3%
1/43 • Number of events 1 • Up to 64 weeks
|
|
Renal and urinary disorders
Nocturia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Renal and urinary disorders
Pollakiuria
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Renal and urinary disorders
Renal colic
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Renal and urinary disorders
Renal failure
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Amenorrhoea
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Balanoposthitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Benign prostatic hyperplasia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Breast calcifications
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Breast mass
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Breast pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Dysmenorrhoea
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.90%
4/443 • Number of events 10 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Ectropion of cervix
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Erectile dysfunction
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Menstruation irregular
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Metrorrhagia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Oligospermia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Ovarian cyst
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Penile erythema
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Pruritus genital
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Testicular pain
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Vaginal haemorrhage
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Vulvovaginal dryness
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Reproductive system and breast disorders
Vulvovaginal pruritus
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Asthma
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.33%
3/904 • Number of events 5 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 3 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Bronchial hyperreactivity
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Chronic obstructive pulmonary disease
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Cough
|
3.6%
4/112 • Number of events 4 • Up to 64 weeks
|
1.6%
7/448 • Number of events 7 • Up to 64 weeks
|
1.4%
13/904 • Number of events 13 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
2.7%
12/437 • Number of events 14 • Up to 64 weeks
|
1.6%
7/434 • Number of events 9 • Up to 64 weeks
|
1.1%
5/443 • Number of events 6 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
5.7%
2/35 • Number of events 2 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Dysphonia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Dyspnoea
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Epistaxis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Hypoxia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Interstitial lung disease
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Laryngeal pain
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Lower respiratory tract congestion
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Nasal congestion
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.66%
6/904 • Number of events 6 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Nasal discomfort
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Nasal polyps
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Nasal septum deviation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Oropharyngeal pain
|
1.8%
2/112 • Number of events 2 • Up to 64 weeks
|
2.5%
11/448 • Number of events 12 • Up to 64 weeks
|
0.77%
7/904 • Number of events 7 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.92%
4/437 • Number of events 6 • Up to 64 weeks
|
0.92%
4/434 • Number of events 4 • Up to 64 weeks
|
2.5%
11/443 • Number of events 11 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Paranasal sinus discomfort
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Pharyngeal erythema
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Productive cough
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary embolism
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary mass
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory disorder
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory distress
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Rhinitis allergic
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.44%
4/904 • Number of events 4 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.4%
6/437 • Number of events 6 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Rhinorrhoea
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.33%
3/904 • Number of events 4 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.69%
3/437 • Number of events 4 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Sinus congestion
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Sleep apnoea syndrome
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Sneezing
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Throat tightness
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Respiratory, thoracic and mediastinal disorders
Upper respiratory tract inflammation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Acanthosis nigricans
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Acne
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.66%
6/904 • Number of events 6 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Actinic keratosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 4 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 4 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Alopecia
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Alopecia areata
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Angioedema
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 3 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Asteatosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Blister
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Dermal cyst
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Dermatitis
|
0.00%
0/112 • Up to 64 weeks
|
0.67%
3/448 • Number of events 3 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Dermatitis allergic
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Dermatitis contact
|
0.00%
0/112 • Up to 64 weeks
|
0.89%
4/448 • Number of events 4 • Up to 64 weeks
|
0.55%
5/904 • Number of events 5 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
1.1%
5/437 • Number of events 5 • Up to 64 weeks
|
1.2%
5/434 • Number of events 5 • Up to 64 weeks
|
2.0%
9/443 • Number of events 9 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
3.4%
1/29 • Number of events 1 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
2.3%
1/43 • Number of events 1 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Drug eruption
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Dry skin
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Dyshidrotic eczema
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Ecchymosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 2 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Eczema
|
0.00%
0/112 • Up to 64 weeks
|
0.67%
3/448 • Number of events 3 • Up to 64 weeks
|
1.2%
11/904 • Number of events 14 • Up to 64 weeks
|
5.3%
1/19 • Number of events 1 • Up to 64 weeks
|
2.3%
10/437 • Number of events 11 • Up to 64 weeks
|
1.4%
6/434 • Number of events 6 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Eczema asteatotic
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Eczema nummular
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Erythema
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 3 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Granuloma annulare
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Hand dermatitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Hyperhidrosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.33%
3/904 • Number of events 3 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Ingrown hair
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Intertrigo
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Keratosis pilaris
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Lentigo
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Leukoplakia
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Lichen planus
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Lichen sclerosus
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Macule
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Miliaria
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Myxoid cyst
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Nail psoriasis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Night sweats
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Onychoclasis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Pain of skin
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Papule
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Papulopustular rosacea
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Petechiae
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Photodermatosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Photosensitivity reaction
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Pityriasis rosea
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Pityriasis rubra pilaris
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Polymorphic light eruption
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Post inflammatory pigmentation change
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Prurigo
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Pruritus
|
1.8%
2/112 • Number of events 4 • Up to 64 weeks
|
0.89%
4/448 • Number of events 4 • Up to 64 weeks
|
2.4%
22/904 • Number of events 22 • Up to 64 weeks
|
10.5%
2/19 • Number of events 2 • Up to 64 weeks
|
1.8%
8/437 • Number of events 8 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.90%
4/443 • Number of events 5 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Pruritus allergic
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Psoriasis
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Purpura
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Rash
|
0.00%
0/112 • Up to 64 weeks
|
0.67%
3/448 • Number of events 3 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Rash papular
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Rash pruritic
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Rash vesicular
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Rosacea
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Seborrhoea
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Seborrhoeic dermatitis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.68%
3/443 • Number of events 3 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Sensitive skin
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Skin atrophy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Skin fissures
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Skin mass
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Skin ulcer
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Solar dermatitis
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Toxic skin eruption
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Urticaria
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.88%
8/904 • Number of events 10 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.69%
3/434 • Number of events 3 • Up to 64 weeks
|
0.90%
4/443 • Number of events 4 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
11.1%
1/9 • Number of events 1 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Urticaria cholinergic
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Urticaria chronic
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Skin and subcutaneous tissue disorders
Xeroderma
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Social circumstances
Menopause
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Social circumstances
Stress at work
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Abscess drainage
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Antiviral prophylaxis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 3 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Bile duct stent insertion
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
2.3%
1/43 • Number of events 1 • Up to 64 weeks
|
|
Surgical and medical procedures
Cataract operation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.45%
2/443 • Number of events 4 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Cervix cryotherapy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Cholangiostomy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
2.3%
1/43 • Number of events 1 • Up to 64 weeks
|
|
Surgical and medical procedures
Cholecystectomy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Dental care
|
0.00%
0/112 • Up to 64 weeks
|
0.45%
2/448 • Number of events 2 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Dental implantation
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Dental prosthesis placement
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Endodontic procedure
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Female sterilisation
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Foot operation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Hernia repair
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Infusion
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Intestinal polypectomy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Joint surgery
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Lens extraction
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
5.6%
1/18 • Number of events 1 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Limb operation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Lipoma excision
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Mass excision
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Meniscus removal
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Nephrostomy
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Percutaneous coronary intervention
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
5.3%
1/19 • Number of events 2 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Phlebectomy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Rehabilitation therapy
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Removal of foreign body
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Rotator cuff repair
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Shoulder operation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Skin neoplasm excision
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Tooth extraction
|
0.89%
1/112 • Number of events 1 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.22%
2/904 • Number of events 2 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.46%
2/437 • Number of events 2 • Up to 64 weeks
|
0.46%
2/434 • Number of events 2 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Surgical and medical procedures
Varicose vein operation
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Arteriosclerosis
|
0.00%
0/112 • Up to 64 weeks
|
0.22%
1/448 • Number of events 1 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Deep vein thrombosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Essential hypertension
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Haemorrhage
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.23%
1/443 • Number of events 1 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Hot flush
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Hypertension
|
3.6%
4/112 • Number of events 4 • Up to 64 weeks
|
2.0%
9/448 • Number of events 9 • Up to 64 weeks
|
2.7%
24/904 • Number of events 25 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
2.1%
9/437 • Number of events 9 • Up to 64 weeks
|
1.8%
8/434 • Number of events 8 • Up to 64 weeks
|
1.8%
8/443 • Number of events 8 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Hypotension
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Orthostatic hypotension
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Peripheral venous disease
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Phlebitis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Raynaud's phenomenon
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Thrombophlebitis superficial
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.23%
1/434 • Number of events 1 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Varicose vein
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.00%
0/904 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.23%
1/437 • Number of events 1 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
Venous thrombosis
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
|
Vascular disorders
White coat hypertension
|
0.00%
0/112 • Up to 64 weeks
|
0.00%
0/448 • Up to 64 weeks
|
0.11%
1/904 • Number of events 1 • Up to 64 weeks
|
0.00%
0/19 • Up to 64 weeks
|
0.00%
0/437 • Up to 64 weeks
|
0.00%
0/434 • Up to 64 weeks
|
0.00%
0/443 • Up to 64 weeks
|
0.00%
0/104 • Up to 64 weeks
|
0.00%
0/18 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/4 • Up to 64 weeks
|
0.00%
0/9 • Up to 64 weeks
|
0.00%
0/1 • Up to 64 weeks
|
0.00%
0/29 • Up to 64 weeks
|
0.00%
0/35 • Up to 64 weeks
|
0.00%
0/14 • Up to 64 weeks
|
0.00%
0/6 • Up to 64 weeks
|
0.00%
0/43 • Up to 64 weeks
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place